Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria
Top Cited Papers
- 27 February 2001
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 56 (4), 537-539
- https://doi.org/10.1212/wnl.56.4.537
Abstract
The authors performed clinical–pathologic correlation to assess the validity of the Boston diagnostic criteria for cerebral amyloid angiopathy (CAA). Thirteen subjects were diagnosed clinically with probable CAA from among 39 patients with available pathologic tissue in a prospective cohort of subjects aged ≥55 years with primary lobar hemorrhage. All 13 individuals were confirmed neuropathologically as having CAA. This small pathologic series indicates that the diagnosis of probable CAA can be made during life with high accuracy.Keywords
This publication has 8 references indexed in Scilit:
- Apolipoprotein E Genotype and the Risk of Recurrent Lobar Intracerebral HemorrhageNew England Journal of Medicine, 2000
- Cerebral amyloid angiopathyNeurology, 1998
- Diagnosis of Cerebral Amyloid AngiopathyStroke, 1997
- High frequency of apolipoprotein E ϵ2 Allele in hemorrhage due to cerebral amyloid angiopathyAnnals of Neurology, 1997
- Apolipoprotein E ε4 Is Associated With the Presence and Earlier Onset of Hemorrhage in Cerebral Amyloid AngiopathyStroke, 1996
- Petechial hemorrhages accompanying lobar hemorrhageNeurology, 1996
- Cerebral amyloid angiopathy: A significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderlyJournal of the Neurological Sciences, 1993
- Cerebral amyloid angiopathy. A critical review.Stroke, 1987